![]() |
市场调查报告书
商品编码
1829225
2025年数位病理学全球市场报告Digital Pathology Global Market Report 2025 |
近年来,数位病理学市场快速扩张,从2024年的12.2亿美元成长到2025年的14.2亿美元,复合年增长率达15.7%。这段时期的成长可归因于老年人口的快速成长、医疗事故的增加、癌症发生率的上升、慢性病的增加、医疗机构数量的增加、医疗支出的增加、公共医疗保险改革以及新冠疫情。
预计未来几年数位病理学市场将快速成长,到2029年将达到27.9亿美元,复合年增长率为18.4%。预测期内的成长归因于政府支持、数位设备普及率的提高、癌症和慢性病发病率的上升、人口老化以及感染疾病的出现。预测期内的主要趋势包括利用人工智慧提高自动化程度、专注于云端技术以标准化和简化数位病理学部署、采用数位成像和视讯串流技术、专注于开发新的技术解决方案、透过伙伴关係关係扩展产品系列以及投资研发活动。
数位病理学将数位成像引入病理学测试,使用载玻片扫描器硬体、软体和相关服务将玻璃载玻片转换为可以在电脑或行动电话萤幕上查看、管理和分析的高解析度数位影像。
数位病理学的关键产品包括扫描器、软体、通讯系统和储存系统。扫描仪利用显微阵列技术创建病理切片的三维数位表示,以供检视和自动影像分析。软体有助于影像审查、分析和将数据传输为数位格式,以进行组织学成像分析。通讯系统有助于切片的收集、储存、检视以及各个组件之间的交互,以便与远端同事进行即时远端病理分析。储存系统包括用于长期样本分析和预测分析的数位檔案。病理学分为人类病理学和兽医病理学。数位病理学的应用范围广泛,包括製药和生物技术公司、医院、参考实验室以及学术和研究机构。应用范围从药物研发和疾病诊断到远距会诊、培训和教育。
2025年春季,美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供数位病理学市场统计数据,例如全球数位病理学市场规模、各地区市场份额、竞争对手的市场份额、详细的数位病理学细分市场、市场趋势和商业机会,以及您在数位病理学行业取得成功所需的数据。本数位病理学市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切资讯的完整观点。
未来五年的预测成长率为18.4%,较我们先前对该市场的预测略有下降0.3%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国,导致来自瑞典和新加坡等主要地区的全切片成像扫描仪和云端基础影像分析平台的供应链中断,这可能导致癌症诊断延迟和实验室数位转型成本增加。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,这种影响可能会更加广泛。
癌症发生率的上升是数位病理学市场扩张的主要原因。随着人口老化,由于细胞变化和长期暴露于各种风险因素,罹患癌症的可能性增加。此外,吸烟、不良饮食、缺乏运动和过量饮酒等生活方式选择进一步增加了癌症的风险。数位病理学能够快速诊断和治疗癌症,使其成为管理这一日益严重的健康问题的重要工具。例如,2024 年 1 月,美国致力于癌症宣传的美国癌症协会报告称,癌症患者数量从 2023 年的 1,958,310 人增加到 2024 年的 2,001,140 人,增加了 2.19%。因此,预计未来癌症患者数量的增加将推动数位病理学市场的成长。
数位病理学市场预计将受益于感染疾病的出现和新病原体的传播。 SARS、兹卡病毒、伊波拉出血热和 COVID-19 等疾病的爆发导致全球感染疾病增加,增加了全球疾病负担。数位病理学有助于对疑似感染疾病的病理诊断进行即时咨询,使病理学家、实验室技术人员和其他专家能够有效协作。通用感染疾病是起源于动物并进化以感染人类的疾病。它们占已知人类病原体的约 60% 和新兴人类病原体的 75%。气候变迁预计将透过影响微生物及其媒介的地理范围来改变感染疾病的流行病学。随着微生物适应更高的温度,能够突破人类防御的耐热微生物将被选择,这可能导致新感染疾病的出现和现有疾病流行病学的变化。这种动态场景正在推动对数位病理学的需求并支持市场成长。
过去,训练有素的病理学家短缺曾为数位病理学市场带来挑战。病理学家在进行疾病诊断所必需的实验室检测(包括医学样本的检查和解读)方面发挥着至关重要的作用。亚太和非洲国家的病理学家短缺正在影响医学样本的及时检测。例如,2022年2月, 《法医学杂誌》的一篇报告指出,有217具尸体积压等待国家法医学病理学家的检验,并预测这一数字将在两週内上升到300具。此外,还有200多具尸体等待尸检,凸显了病理学家资源的紧张。
人工智慧 (AI) 是数位病理学市场中一个日益突出的趋势。医疗保健公司正在利用 AI 来增强各种业务流程的自动化。使用影像分类的 AI 演算法有助于检测与人类疾病(例如癌细胞)以及农业问题(例如叶片变色和腐烂)相关的特征。 2022 年 1 月,美国病理实验室 Inform Diagnostics 在其实验室中引入了 Paige FullFocus 数位病理学检视器。这项新技术的引入使 Inform Diagnostics 的病理学家能够利用 AI 工具、简化物流并加快结果获取速度。
2022年3月,总部位于英国的综合实验室服务和产品供应商SourceBio International PLC成功以1,850万英镑(1,976万美元)收购了LDPath Ltd。该公司计划利用过去两年COVID-19 PCR检测服务产生的资金,策略性地回购股份。此次收购将增强SourceBio International作为英国NHS信託机构和私人医疗保健提供者领先的细胞病理学检测外包合作伙伴的地位。扩大后的集团旨在推动NHS和私人客户采用数位病理学服务。 LDPath是一家总部位于英国的专业数位病理学检测服务提供者。
数位病理学市场的主要企业包括丹纳赫集团、霍夫曼罗氏有限公司、荷兰皇家飞利浦公司、滨松光子学株式会社、3DHISTECH 有限公司、奥林巴斯公司、尼康公司、Visiopharm A/S、Indica Labs Inc、Sectra AB、Grundium、徕卡生物系统成像公司、阿波罗公司Doc、Ventana Medical Systems、Huron Digital Pathology、Synevo、Paige.ai、Morphle、Akoya、Aperio Digital Pathology、Smart in Media、MaRS、珀金埃尔默、Definiens AG、Digipath、CAE、Medical-X、C3+ Holter Monitor、BIOEGYPT 和 Pulse。
2024年,数位病理学市场最大的地区是北美。亚太地区是数位病理学市场的第二大地区。数位病理学市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
数位病理学市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、西班牙和加拿大。
数位病理学市场包括切片扫描仪、软体和试剂的销售。该市场的价值指的是“出厂价”,即商品製造商或创造者向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。
Digital pathology involves utilizing digital imaging for pathology procedures, converting glass slides into high-resolution digital images using slide scanner hardware, software, and related services. These digital images are viewable, manageable, and analyzable on computer or mobile screens.
Key products in digital pathology include scanners, software, communication systems, and storage systems. Scanners utilize microscopic array technology to create three-dimensional digital representations of pathology slides for viewing and automated image analysis. Software aids in transferring data to digital formats for image review, analysis, and tissue image analysis. Communication systems facilitate interaction between various components for slide acquisition, storage, viewing, and real-time telepathology with remote colleagues. Storage systems involve digital archives for long-term sample analysis and predictive analytics. Pathology branches into human pathology and veterinary pathology. Digital pathology finds application across pharmaceutical & biotechnology companies, hospitals, reference laboratories, academic & research institutes. Its uses encompass drug discovery, disease diagnosis, teleconsultation, and training & education purposes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The digital pathology market research report is one of a series of new reports from The Business Research Company that provides digital pathology market statistics, including digital pathology industry global market size, regional shares, competitors with a digital pathology market share, detailed digital pathology market segments, market trends and opportunities, and any further data you may need to thrive in the digital pathology industry. This digital pathology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digital pathology market size has grown rapidly in recent years. It will grow from $1.22 billion in 2024 to $1.42 billion in 2025 at a compound annual growth rate (CAGR) of 15.7%. The growth in the historic period can be attributed to rapid growth in the elderly population, increase in medical errors, increase in cancer prevalence, increase in chronic diseases, growth in the number of healthcare facilities, increased healthcare expenditure, public health insurance reforms, and the COVID-19 pandemic.
The digital pathology market size is expected to see rapid growth in the next few years. It will grow to $2.79 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to government support, increasing adoption of digital devices, increasing prevalence of cancer and chronic diseases, aging population, and the emergence of infectious diseases. Major trends in the forecast period include leveraging artificial intelligence to improve automation, focusing on cloud technology to standardize and simplify digital pathology deployments, adopting digital imaging and video streaming technology, focusing on developing new technological solutions, focusing on partnerships to expand product portfolio and investing in research and development (R&D) activities.
The forecast of 18.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for whole-slide imaging scanners and cloud-based image analysis platforms, sourced from key regions such as Sweden and Singapore, which could lead to delayed cancer diagnoses and increased laboratory digital transformation costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of cancer is significantly contributing to the expansion of the digital pathology market. As populations age, the likelihood of developing cancer increases due to cellular changes and prolonged exposure to various risk factors. Additionally, lifestyle choices such as smoking, poor diet, insufficient physical activity, and excessive alcohol consumption further elevate cancer risk. Digital pathology facilitates quicker diagnosis and treatment of cancer, making it a vital tool in managing this growing health concern. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization focused on cancer advocacy, reported that the number of cancer cases rose to 2,001,140 in 2024, up from 1,958,310 in 2023, marking an increase of 2.19%. Consequently, the rising prevalence of cancer is expected to drive the growth of the digital pathology market in the future.
The digital pathology market is anticipated to receive support from the emergence of infectious diseases and novel pathogenic infestations. Outbreaks of diseases such as SARS, Zika virus, Ebola, and COVID-19 have led to increased infections worldwide, elevating the global disease burden. Digital pathology facilitates real-time consultation for pathologic diagnosis in suspected cases of infectious diseases, enabling professionals such as pathologists and laboratorians to collaborate effectively. Zoonotic infectious agents, which are diseases that originate in animals and evolve to infect humans, account for about 60% of known human pathogens and up to 75% of emerging human pathogens. Climate change is expected to alter the epidemiology of infectious diseases by influencing the geographic ranges of microbes and vectors. As microbes adapt to higher temperatures, concerns arise about the selection of heat-tolerant microbes that can overcome human defenses, leading to new infectious diseases and altering the epidemiology of existing diseases. This dynamic scenario fuels the demand for digital pathology, supporting market growth.
The shortage of trained pathologists posed a challenge to the digital pathology market in the historical period. Pathologists play a crucial role in conducting essential laboratory tests for disease diagnosis, involving the examination and interpretation of medical laboratory samples. The Asia-Pacific region and several African countries face a scarcity of pathologists, impacting the timely examination of medical samples. For instance, in February 2022, a forensic magazine report highlighted a backlog of 217 bodies awaiting examination by state forensic pathologists, with projections of the figure rising to 300 in less than two weeks. Additionally, more than 200 bodies were awaiting autopsies, emphasizing the strain on pathologist resources.
Artificial intelligence (AI) stands out as a prominent trend gaining traction in the digital pathology market. Healthcare companies leverage AI to enhance the automation of various operational processes. AI algorithms, utilizing image classification, contribute to the detection of features associated with human diseases, such as cancer cells, and agricultural issues such as leaf coloring and decay. In January 2022, Inform Diagnostics, a US-based pathology lab, introduced the Paige FullFocus digital pathology viewer in its laboratories. This adoption of new technology empowers pathologists at Inform Diagnostics to leverage AI tools, streamline logistics, and achieve faster turnaround times for results.
In March 2022, SourceBio International PLC, a UK-based provider of integrated laboratory services and products, successfully completed the acquisition of LDPath Ltd for an initial amount of £18.5 million ($19.76 million). The company is strategically planning a share buyback, utilizing the funds generated from its Covid PCR testing services over the preceding two years. This acquisition enhances SourceBio International's position, aiming to become the leading outsourced partner for delivering cellular pathology testing to NHS trusts and private healthcare providers in the UK. The expanded group has set its sights on converting both NHS and private clients to embrace digital pathology services. LDPath Ltd is a UK-based provider specializing in digital pathology testing services.
Major companies operating in the digital pathology market include Danaher Corporation, Hoffmann-La Roche Ltd, Koninklijke Philips N.V, Hamamatsu Photonics K.K, 3DHISTECH Ltd, Olympus Corporation, Nikon Corporation, Visiopharm A/S, Indica Labs Inc, Sectra AB, Grundium, Leica Biosystems, Apollo Enterprise Imaging Corp, Inspirata Inc, PathAI, Aiforia Technologies, Proscia, Ibex Medical Analytics, Better Doc, Ventana Medical Systems, Huron Digital Pathology, Synevo, Paige.ai, Morphle, Akoya, Aperio Digital Pathology, Smart in Media, MaRS, Perkin Elmer, Definiens AG, Digipath, CAE, Medical-X, C3? Holter Monitor, BIOEGYPT, Pulse
North America was the largest region in the digital pathology market in 2024. Asia-Pacific was the second-largest region in the digital pathology market. The regions covered in the digital pathology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital pathology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The digital pathology market consists of the sales of slide scanners, software, and reagents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Pathology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digital pathology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for digital pathology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital pathology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.